Pembrolizumab associated hemophagocytic lymphohistiocytosis

Ann Oncol. 2017 Jun 1;28(6):1403. doi: 10.1093/annonc/mdx113.

Authors

D Shah¹, R Shrestha¹, R Ramlal¹, J Hatton¹, H Saeed¹

Affiliation

¹ Hematology and Bone and Marrow Transplantation, University of Kentucky, Lexington, USA.

PMID: 28368439
DOI: 10.1093/annonc/mdx113

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal, Humanized / administration & dosage
Antibodies, Monoclonal, Humanized / adverse effects*
Antineoplastic Agents, Immunological / administration & dosage
Antineoplastic Agents, Immunological / adverse effects*
Humans
Lymphohistiocytosis, Hemophagocytic / chemically induced*
Lymphohistiocytosis, Hemophagocytic / immunology
Male
Urinary Bladder Neoplasms / drug therapy
Urinary Bladder Neoplasms / immunology
Urinary Bladder Neoplasms / pathology

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
pembrolizumab